By admin Posted in News Atamyo completes the dose-finding study in Limb-Girdle Muscular Dystrophy Type R9 (LGMD-R9) and obtains US Rare Pediatric Disease Designation for ATA-100 By admin... Read More
By admin Posted in News AskBio Inc. Advances Gene Therapy Clinical Trial for LGMD2I/R9 with Dosing of First Participant in Second Cohort By admin... Read More
